Delivery Order SPE2DB22D2009-SPE2DB25FL5YP

Award Date 10/16/24
Potential Completion Date 10/17/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx UNOREADY 300 mg pen injectors, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed-price of $12,175.29 and an ultimate completion date of December 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This appears to be a delivery order issued under a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,525.01 firm fixed-price contract is for the delivery of Cosentyx Unoready 300 mg pen injectors. The award is associated with a $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,131.70 firm-fixed-price delivery order is for the supply of Cosentyx Unoready 300 mg pen injectors. The award is not associated with a set-aside program. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through 2025. This IDC serves as the...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pens to the Defense Logistics Agency (DLA). The $3,136.32 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through May 25, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,274.76 firm fixed-price delivery order is to provide Cosentyx Unoready 300 mg pens to support the DLA's medical supply needs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen subcutaneous injections to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,106.01 and an ultimate completion date of December 22, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen injections to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,131.76 and an ultimate completion date of November 9, 2022. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The $9,131.70 firm fixed price delivery order is for the supply of Cosentyx Unoready 300 mg pen, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
This federal contract award is for the delivery of Cosentyx 300 mg dose injector pens to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 29, 2023, with a ceiling value of $1,696.37 and a completion date of March 30, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx Unoready 300 mg pen injectors. The firm-fixed-price contract has a ceiling value of $27,745.00 and a performance period through August 27, 2024. It was awarded on August 26, 2024 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL5YP
    Delivery Order

This federal contract award is for the delivery of Cosentyx Unoready 300 mg pen injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,837.91 firm fixed price contract was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 1/15/25, 9:18 AM